Christopher Vaughn, MD 

The Right-In-Time clinical trial network eliminates repetitive contracting, feasibility and site qualification activities so providers can focus on treating their patients, rather than the administrative burden of clinical trial start-up. The Caris team works with the site to develop, review and submit required regulatory paperwork and documentation.

The Caris Molecular Tumor Board provides oncologists with the opportunity to interact with leading cancer experts from across the country to obtain interpretation of molecular findings and therapeutic guidance for individual patients.